NYSE: ALC
Alcon Inc Stock

$86.20-2.92 (-3.28%)
Updated Jun 13, 2025
ALC Price
$86.20
Fair Value Price
N/A
Market Cap
$42.73B
52 Week Low
$80.48
52 Week High
$101.10
P/E
38.14x
P/B
1.94x
P/S
4.74x
PEG
1.8x
Dividend Yield
N/A
Revenue
$9.93B
Earnings
$1.12B
Gross Margin
55.5%
Operating Margin
15.43%
Profit Margin
11.3%
Debt to Equity
0.41
Operating Cash Flow
$2B
Beta
0.83
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ALC Overview

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and glaucoma surgery. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR ophthalmic microscope, verion imaged guided system, and ORA System for intra-operative measurements and guidance; vitreoretinal products comprising constellation vision system, grieshaber DSP and MIVS instrumentation, ultravit high speed vitrectomy probes, purepoint laser, and NGENUITY 3D visualization system; refractive surgery products, including WaveLight lasers and diagnostics used for LASIK; and glaucoma product, such as EX-PRESS glaucoma filtration device, as well as AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. The Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers under the TOTAL, PRECISION, Dailies, Air Optix, Systane, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ALC's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
B
ALC
Ranked
#24 of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$6.21A
$9.56B
$15.63B
View Top Medical Stocks

Be the first to know about important ALC news, forecast changes, insider trades & much more!

ALC News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ALC ($86.20) is trading above its intrinsic value of $29.31, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ALC is poor value based on its earnings relative to its share price (38.14x), compared to the US market average (31.36x)
P/E vs Market Valuation
ALC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ALC due diligence checks available for Premium users.

Valuation

ALC price to earnings (PE)

For valuing profitable companies with steady earnings

Company
38.14x
Industry
38.52x
Market
31.36x
ALC is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ALC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ALC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.94x
Industry
3.59x
ALC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ALC price to earnings growth (PEG)

For valuing profitable companies with growth potential

ALC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ALC's financial health

Profit margin

Revenue
$2.5B
Net Income
$350.0M
Profit Margin
14.2%
ALC's Earnings (EBIT) of $1.53B... subscribe to Premium to read more.
Interest Coverage Financials
ALC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$31.0B
Liabilities
$9.0B
Debt to equity
0.41
ALC's short-term assets ($6.07B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALC's long-term liabilities ($6.74B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$384.0M
Investing
-$578.0M
Financing
-$96.0M
ALC's operating cash flow ($2.12B)... subscribe to Premium to read more.
Debt Coverage Financials

ALC vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ALCC$42.73B-3.28%38.14x1.94x
RMDC$36.56B-1.14%27.89x6.59x
BDXC$49.36B-1.29%33.25x1.96x
WSTC$15.94B-1.33%34.57x5.94x
BAXC$15.71B-2.36%-27.84x2.22x

Alcon Stock FAQ

What is Alcon's quote symbol?

(NYSE: ALC) Alcon trades on the NYSE under the ticker symbol ALC. Alcon stock quotes can also be displayed as NYSE: ALC.

If you're new to stock investing, here's how to buy Alcon stock.

What is the 52 week high and low for Alcon (NYSE: ALC)?

(NYSE: ALC) Alcon's 52-week high was $101.10, and its 52-week low was $80.48. It is currently -14.74% from its 52-week high and 7.11% from its 52-week low.

How much is Alcon stock worth today?

(NYSE: ALC) Alcon currently has 495,700,000 outstanding shares. With Alcon stock trading at $86.20 per share, the total value of Alcon stock (market capitalization) is $42.73B.

Alcon stock was originally listed at a price of $58.04 in Apr 9, 2019. If you had invested in Alcon stock at $58.04, your return over the last 6 years would have been 48.52%, for an annualized return of 6.81% (not including any dividends or dividend reinvestments).

How much is Alcon's stock price per share?

(NYSE: ALC) Alcon stock price per share is $86.20 today (as of Jun 13, 2025).

What is Alcon's Market Cap?

(NYSE: ALC) Alcon's market cap is $42.73B, as of Jun 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Alcon's market cap is calculated by multiplying ALC's current stock price of $86.20 by ALC's total outstanding shares of 495,700,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.